Allogenic hematopoietic stem cell transplantation is feasible in pediatric patients with an active or recently diagnosed invasive fungal infection
Allogenic hematopoietic stem cell transplantation (HSCT) is the treatment of choice for a variety of hematologic malignancies as well as a range of nonmalignant disorders. Evolution of transplant management and progress in supportive care including the initiation of antimicrobial prophylaxis has improved survival after allogenic HSCT over the last decades.
Source: Biology of Blood and Marrow Transplantation - Category: Hematology Authors: Laura G.Y. Rotte, Yvette G.T. Loeffen, Marc B. Bierings, Tom F.W. Wolfs, Caroline A. Lindemans Source Type: research
More News: Biology | Cancer & Oncology | Fungal Infections | Hematology | Pediatrics | Stem Cell Therapy | Stem Cells | Transplants